Skip to main content
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2019 Mar 4;10:395. doi: 10.3389/fmicb.2019.00395

Artificial Neural Networks for Prediction of Tuberculosis Disease

Muhammad Tahir Khan 1,2,, Aman Chandra Kaushik 2,, Linxiang Ji 3, Shaukat Iqbal Malik 1,*, Sajid Ali 4, Dong-Qing Wei 2,*
PMCID: PMC6409348  PMID: 30886608

Abstract

Background: The global burden of tuberculosis (TB) and antibiotic resistance is attracting the attention of researchers to develop some novel and rapid diagnostic tools. Although, the conventional methods like culture are considered as the gold standard, they are time consuming in diagnostic procedure, during which there are more chances in the transmission of disease. Further, the Xpert MTB/RIF assay offers a fast diagnostic facility within 2 h, but due to low sensitivity in some sample types may lead to more serious state of the disease. The role of computer technologies is now increasing in the diagnostic procedures. Here, in the current study we have applied the artificial neural network (ANN) that predicted the TB disease based on the TB suspect data.

Methods: We developed an approach for prediction of TB, based on an ANN. The data was collected from the TB suspects, guardians or care takers along with samples, referred by TB units and health centers. All the samples were processed and cultured. Data was trained on 12,636 records of TB patients, collected during the years 2016 and 2017 from the provincial TB reference laboratory, Khyber Pakhtunkhwa, Pakistan. The training and test set of the suspect data were kept as 70 and 30%, respectively, followed by validation and normalization. The ANN takes the TB suspect’s information such as gender, age, HIV-status, previous TB history, sample type, and signs and symptoms for TB prediction.

Results: Based on TB patient data, ANN accurately predicted the Mycobacterium tuberculosis (MTB) positive or negative with an overall accuracy of >94%. Further, the accuracy of the test and validation were found to be >93%. This increased accuracy of ANN in the detection of TB suspected patients might be useful for early management of disease to adopt some control measures in further transmission and reduce the drug resistance burden.

Conclusion: ANNs algorithms may play an effective role in the early diagnosis of TB disease that might be applied as a supportive tool. Modern computer technologies should be trained in diagnostics for rapid disease management. Delays in TB diagnosis and initiation treatment may allow the emergence of new cases by transmission, causing high drug resistance in countries with a high TB burden.

Keywords: ANN, TB, data, diagnosis, drug resistance

Introduction

According to the (World Health Organization [WHO], 2018), 1.7 billion people (23%) of the world’s population are estimated to have latent TB infection, indicating a risk of developing active TB during their lifetime (World Health Organization [WHO], 2018). Approximately 10.4 million incidences of TB occurred worldwide, including 5 million (56%) men, 3.5 million (34%) women and 1 million (10%) among children (WHO, 2017). Due to an increase in the world’s population, the health care units are continuously struggling to improve the standard and reduce the transmission and cost. Methods commonly used to diagnose TB include, GeneXpert assay, sputum-smear microscopy and chest radiography (Dheda et al., 2017; Ejeta et al., 2018). However, diagnosis became more complicated when the infectious agent spread to other parts of the body – this is referred to as extra pulmonary TB. All these diagnostic methods possess some limitations. Culture method is considered the gold standard for detection of the causative agent of TB, Mycobacterium tuberculosis (MTB) but it is time consuming in diagnosis and the chances of contamination are high (Crowle et al., 1991; Osman et al., 2010; Asgharzadeh et al., 2015). Some common issues reported from other diagnostics methods include performance issues, sputum samples from children (pediatric cases), live MTB, highly skilled medical staff for high throughput tools and high cost (Dheda et al., 2017; Pandey et al., 2017). Delay in diagnosis may lead to drug resistance, multidrug resistance (MDR), where an isolate shows resistance to two first line drugs, rifampicin and isoniazid, and extensive drug resistance (XDR) which include MDR and also show resistance to fluoroquinolones and at least one of the injectable drug (Seung et al., 2015).

In health sciences, wet lab tests can be time consuming and the chances of contamination could further lead the disease to an irreversible state. Although the Xpert MTB/RIF assay offers a fast diagnostic facility within 2 h, but due to low sensitivity in some sample types and cost may lead to more serious state of disease (Pandey et al., 2017).

In the last few decades, the researchers have collected an extensive amount of biological data in genomics, proteomics, and in some other fields of biology during the gene and protein expression analysis. To extract some meaningful information and interpret the results, high throughput computational algorithms have been developed (Fojnica et al., 2016; Dande and Samant, 2018). In bioinformatics, data mining is a process of extracting useful information deep inside of large datasets (Sebban et al., 2002; Zheng et al., 2008; Li et al., 2013). These techniques also involve artificial intelligence, statistics, machine learning, and visualization (Li et al., 2013; Dande and Samant, 2018). Such techniques are applied to expose and analyze the hidden information inside the data or sometimes also called Intelligent Data Analysis (IDA), for better prediction of results. This knowledge discovery obtained from health data has some major objectives, including diagnosis in health sciences and simulations (Mello et al., 2006; Guillet and Hamilton, 2007; Chang et al., 2012).

Traditionally implemented diagnostic methods for tuberculosis patients can be minimized with data mining approaches. National and International laboratory researchers are currently involved in developing new diagnostics, and their evaluation helps to introduce more rapid and accurate methods in the diagnosis of TB along with the evaluations of alternative algorithms for TB reference laboratories (Parsons et al., 2011).

Artificial Neural Networks (ANNs) are operated by using algorithms to interpret non-linear data, independent of sequential pattern. The networks consist of a number of smaller units called neurons, organized between the input of data and the output of results into many layers. The ANN perform and behave like biological neurons, and this behavior may be learned through a backpropagation process. In this process, the precise output of a data set is previously known as input into the network. The least mean square difference of the entire data set is minimized by the continuous comparison of output of the ANN to the known output. A good level precision is adjusted by performing complex tasks without many computing resources (Drew and Monson, 2000).

The main advantage usually provided by ANN is their capability to extract hidden linear and non-linear relationships, even in the high dimensional and complex data sets (Zhang et al., 2010). In order to ease clinical decision makers, some more rapid evaluation techniques with low costs and good precision may further support in the diagnosis of TB to give optimum time for therapy, especially in TB high burden countries. Modern methods in data mining along with some traditional methods like regression have proven to be useful for comparison of prediction power of different models. The objective behind the current study is to support physicians in diagnosis, using predictive models as a diagnostic method for TB. Here, this investigation presents the data mining methods, i.e., classification, decision tree algorithm on the TB suspect data sets with selected attributes of patients to predict the presence or absence of TB disease. This information can be applied to develop less expensive diagnostic methods, dropping drug effects, data modeling, management of health care information systems, public health, and also patient’s future prediction.

Materials and Methods

Ethics Statement

This study proposal was approved and permitted by Institutional Committee (Ref 30/CUST2017) and incharge and molecular biologist, Provincial Tuberculosis Research Lab (PTRL) (Ref No. 1-06-17) where individual patient names and sensitive information were removed and neither of the these have been linked with an individual TB suspect. Further, the study was also conducted according to the WHO Standards and Operational Guidance for Ethics Review of World Health Organization [WHO] (2011). Annex-3(IV)-B (13).

Data Mining of TB Patient Data

Data in the current research was retrieved from TB control program at PTRL, Hayatabad Medical Complex Peshawar. All follow up and diagnostic patients have been included and the data of patients has been collected from guardians or care takers. The data include location, age, gender, sample type, history, HIV status. The data set contain information’s from 36 different TB units of Khyber Pakhtunkhwa (KPK). The characteristics of data is given Table 1, 2.

Table 1.

Characteristics of TB suspects/patients received from KPK TB units.

Characteristics No. Characteristics No. Characteristics No.
Gender Hiv status Sample type
Female 6445 Hiv +ve 534 Sputum 11089
Male 6043 Hiv −ve 5 Pleural fluid 343
Other 148 Unknown 12097 BAL 312
Total 12636 Total 12636 Gastric aspirate 224
CSF 172
History Age group Pus 124
Diagnosis 10416 0.1–14 1072 Ascetic fluid 117
Follow up 2220 15–24 3474 Tissue 104
Total 12636 25–34 2438 Urine 69
35–44 1678 Pericardial fluid 43
Disease type 45–54 1690 Synovial fluid 16
Extra pulmonary 1323 55–64 1336 Lymph node 11
Pulmonary 11313 65–74 661 Total 12636
Total 12636 75–84 222 Culture
85–94 55 MTB 1809
95–104 8 No growth 10827
100–105 2 Total 12636
Total 12636

CSF, cerebrospinal fluid; BAL, bronchoalveolar lavage; Other, she male.

Table 2.

Number of TB suspects received from different units of KPK province.

S.No. Health center Cases S.No. Health center Cases
1 ATO Khyber agency 71 20 DTO Sawabi 32
2 CMH 296 21 DTO Shangla 4
3 DTO Bajawar agency 11 22 DTO Swat 6
4 DTO Bannu 8 23 Hayatabad medical complex 1903
5 DTO Buner 8 24 Khyber teaching hospital 699
6 DTO Charsadda 54 25 Kuwait hospital 21
7 DTO Chitral 5 26 Leady reading hospital 2
8 DTO D.I. Khan 8 27 Mardan medical complex 8
9 DTO Dir Lower 7 28 PMDT ATH 627
10 DTO Dir Upper 13 29 PMDT leady reading hospital 5333
11 DTO Hangu 39 30 PMDT MMTH 1255
12 DTO Kohat 8 31 PMDT Swat 855
13 DTO Kohistan 1 32 Private 2
14 DTO Lakki 2 33 Peshawar reference lab 111
15 DTO Malakand 4 34 Rehman medical institute 66
16 DTO Mansehra 1 35 DTO Takht Nusrati 4
17 DTO Mardan 17 36 TB control Ganj 1
18 DTO Noshera 37
19 DTO Peshawar 1117 Total 12636

ATH, Ayub Teaching Hospital; ATO, Agency TB officers; CMH, Combined Military Hospital; DTO, district TB control officers; MMTH, Mufti Mehmood Teaching Hospital; PMDT, Programmatic Management of Drug Resistant TB.

Dataset Development

Suspects referred by TB units and health care centers during the years 2016 and 2017, were included. Samples were processed and cultured according the previous study (Kent and Kubica, 1985; Khan et al., 2018) and MTB negative and positive was confirmed after the culture result. Further confirmation was carried, using BD MGIT MTBc identification test (TBc ID, Ref: 245159, Becton, Dickinson), a rapid chromatographic immunoassay which detects the MTB complex antigen MPT64 secreted during culture (Arora et al., 2015). The dataset was validated by MATLAB software (Attaway, 2013). Total 12,636 inputs were used in order achieve a good output efficiency, where 70% were used as a training dataset and the remaining 30% were used as testing (Drew and Monson, 2000; Kulkarni et al., 2017). The validation observed for test dataset was about 93.71%.

Artificial Neural Networks Approach

Artificial neural networks are nature inspired algorithms (Fojnica et al., 2016) that include input layer node, hidden layer node, and output node. Every node in a layer has one parallel node in the layer following it, thereby consequently building the stacking. Back-propagation learning algorithm is based on gradient descent search algorithms to fiddle with the correlation weight (Sollich and Krogh, 1996; Kaushik and Sahi, 2018). The output of every neuron was the aggregation of information of neurons of the prior stage multiplied by parallel weights with biased value. Input value was transformed into output with respect to activated functions shown in Figure 1.

FIGURE 1.

FIGURE 1

Neural network structure of MTB dataset where dataset was categorized into three categories input, hidden, and output layers. “W” represent weight parameter with layer node, “B” represent bias unit.

Step 1 – Normalization of MTB Dataset.

TB patients dataset was normalized according to proposed study (Kaushik and Sahi, 2018).

Vnew=(VoldMinV)/(MaxVMinV)(DmaxDmin)+Dmin

where Vnew represent new assessment post-normalization, Vold is the assessment before normalization, MinV is the variable’s minimum assessment, MaxV is the variable’s maximum estimation. Dmax and Dmin are the maximum estimation succeeding normalization and the minimum assessment subsequent to normalization, respectively.

Step 2 – Input the data for training, the interrelated values of input and output execute for training using feed forward back propagation neural network algorithms.

Step 3 – Set Network constraint.

Step 4 – Calculate the neurons of output, every neuron output signal calculated using

netj=i=1~mwijxi+bj

where netj and wji are output neurons and connection weight neurons, respectively, while xi and bj are the input signal, and bias neurons. The sigmoid function or logistic function, also called the sigmoidal curve (Seggern, 2016), was used for netj and every neuron of ten hidden layers.

Step 5 – Signal of output layers’ calculation using,

netk=TVk+δKL

where TVk is target value of output neurons and δKL is the error of neuron.

Step 6 – Compute the error of neuron k and step 3 and step 6 were repetitive until network was congregated, and the error was computed using,

SSE=i=1~n(TiYi)2

where Ti is actual assessment and Yi is estimated assessment.

A step by step flowchart methodology has been given in Figure 1, 2.

FIGURE 2.

FIGURE 2

Flow chart of ANN methodology for data processing, normalization, training, testing, and prediction.

Results

The drug resistance and patient’s characteristics has been shown in Figure 4. MDR are very high among the population of KPK followed by other first line drug resistance. Although XDR are very few, they are very hard to treat and often take years to recover and the chances are very rare. Mono-resistant (resistant to any single drug) and poly resistant (resistant to any two or more drugs other than MDR and XDR) have been found in significant numbers. This high prevalence of drug resistance may be due to the delay type of diagnosis of some gold standard methods like culture. Owing to the current situation, we applied ANN on the patient records to find the accuracy of prediction.

FIGURE 4.

FIGURE 4

(A) Drug resistance among MTB isolates from Khyber Pakhtunkhwa. Frequency of all sensitive, MDR, Mono_Resistant, Poly resistant, and XDR are color coded. (B) Patients data and drug resistance pattern. Drug resistance is shown by red color while drug sensitive isolates are colored yellow. Resistance type (Resist_Type), Sample_Type, TB_Type, previous TB History of patients, and Gender are color coded.

Based on the ANN, the data used in the current study has 12,636 records (Table 1), where 70 and 30% were used as training and test sets, respectively. The accuracies of test and validation to predict TB based on patient data, were found at 93.90 and 93.71%, respectively. ANN-based, this algorithm accurately predicted that a suspect may have TB or not and generated the output through the hidden layer implementation. The hidden layers, learning parameters of ANN were as follows.

Number of input layer units 12636
Number of hidden layers 10
Number of first hidden layer units 10
Number of second hidden layer units 10
Number of output layer units 1
Momentum rate 0.88
Learning rate 0.70
Error after learning 0.000050
Learning cycle 30,000

The Architecture of ANN

  • simple 1.

    Initialize the weight and parameters μ (μ = 0.01)

  • simple 2.

    Compute the sum of the squared errors overall input F(w) = eTe

    Where weight of network w = [w1, w2, w3…. wn] and e is the error vector for the network.

  • simple 3.

    Solve to obtain the increment of weight Δw = [JT J + μI]−1 JT e

    Where J is jacobian matrix, μ is learning rate neither μ is multiplied by decay rate β(0 < β < 1).

  • simple 4.

    Using w+ Δw

    F(w) < F(w) then (go back to Step 2)

    W = w+ Δw

    μ = μ.β (β = 0.1) (go back to Step 2)

    ELSE

    μ = μ/β (go back to Step 2)

    END IF

The approach has been found efficient and possesses robust application for TB disease prediction with prediction accuracy. Using this approach, users can predict the active TB positively or negatively based on the patient’s data after clinical sign symptoms including, cough that lasts 3 weeks or longer and pain in the chest coughing up blood or sputum (mucus from deep inside the lungs). Other symptoms of TB disease may include; weakness or fatigue, weight loss, no appetite, chills, fever, sweating at night (CDC Tuberculosis (TB), 2019).

User input data include; age, gender (male, female, other), sample type [bone, bone marrow, bronchoalveolar lavage, cerebrospinal fluid (CSF), gastric aspirate, lung biopsy, lymph nodes, pericardial fluid, pleural fluid, synovial fluid, pus, tissue biopsy, urine, sputum], history (follow up, diagnostic), HIV status (positive, negative, unknown). The model includes 70% training and 30% test set of the entire data set (12636 records) where the validation score was achieved with an accuracy of 94%.

The approach was written in MATLAB script where prediction accuracy was achieved as >94% based on ANN (Figure 3), dependent on dataset, where dataset input and hidden layer were categorized on two basic parameters W (weight) and B (bias unit), which contain ten sub-models and generate single output based on dataset accuracy. Users can predict their TB risk after entering their data, history, and the appearance of signs and symptoms.

FIGURE 3.

FIGURE 3

Depicts artificial neural network prediction on the basis of normalized data of MTB. Out of 12636 records, 70% was training and 30% was test set where the validation score was achieved with an accuracy of about 94%. The overall model got an accuracy of 94.58%.

Discussion

Tuberculosis is a challenging disease; in spite of advanced technologies, the diagnosis is often difficult because of the nature of the disease (Dheda et al., 2017; WHO, 2017; World Health Organization [WHO], 2018). Clinical diagnosis requires standardization, where immunodiagnostic tests may help to improve sensitivity, but not in latent TB and some lack specificity (Newton et al., 2008; Elhassan et al., 2016). Xpert MTB/RIF have been saving our time to detect MTB, but decades old technologies like culture still remained the standard. Today, the battle against TB still poses one of the primary diagnostic problems in the pediatric laboratory (Dunn et al., 2016). Delay in notification and a weak coordination among TB management might be a cause to unnecessary diagnosis and treatment initiation (Yagui et al., 2006; Htun et al., 2018). Although the Xpert MTB/RIF assay offers fast diagnostic facility within 2 h, in some sample types like lymph node tissue biopsy (extrapulmonary TB) the overall sensitivity to rule out the TB is suboptimal (Creswell et al., 2014; Pandey et al., 2017; Tadesse et al., 2018). Performance was found to vary according to specimen type and acid-fast bacilli smear status. Further, the gold standard for MTB drug susceptibility testing is still culture on solid media, taking weeks to months to grow (Lin and Desmond, 2014; Dookie et al., 2018; Koch et al., 2018). Treatment is often empirical and initiated after looking at factors like past medical or social history, or the prevalence of drug resistance in that locality. These may delay the initiation of proper TB treatment that lead to drug resistance (Schaberg et al., 1996; Melchionda et al., 2013; Dookie et al., 2018; Khan et al., 2018). The high prevalence of drug resistance in TB high burden countries may delay the initiation of appropriate treatment due to culture of MTB in vitro which is a time consuming method. These issues should be addressed through more studies especially in TB high burden regions. We found an increased drug resistance in the recent years’ data (Figure 4) calculation, pointing toward advanced computational technologies to integrate for diagnosis in MTB prediction (Khan et al., 2018).

Modern neural networks have attained a great significance and importance in the recognition of images (Drew and Monson, 2000; Krizhevsky et al., 2012; Esteva et al., 2017; Kaushik and Sahi, 2018), speech recognition (Hinton et al., 2012), and processing of natural language (Socher et al., 2011). Medicinal researchers have started to apply these tactics in personalized clinical care. Diabetic retinopathy has also been identified through the approaches of deep neural networks (Gulshan et al., 2016) and classifying cancers of skin (Esteva et al., 2017). The applications of such approaches have also been found to be successful in computational biology and bioinformatics such as in inferring target gene expression (Chen et al., 2016), predicting RNA-binding protein sites (Zhang et al., 2016), and in identification and prediction of biomarkers for human chronological age (Putin et al., 2016). To reduce cost and time wastage, various data mining approaches may be helpful in diagnosis and on time initiation of TB therapy.

According to the WHO global TB report, 2018, India, Indonesia, China, Philippines, and Pakistan are the top five countries with 56% TB prevalence of the world. Timely TB diagnosis to reduce transmission and initiation of treatment to improve the outcomes for TB patients is essential, especially in high burden countries (Yagui et al., 2006; Dheda et al., 2017).

Classification and clustering algorithms are working efficiently with good precision in the prediction of the tuberculosis diagnosis. Presence of MTB and patient’s data may support such model up to large extents. When handling high-dimensional classification problems, different modeling approaches may be used. Earlier works have applied multivariate logistic regression (Wisnivesky et al., 2005; Solari et al., 2008), classification trees (Mello et al., 2006; Aguiar et al., 2012) and ANN (Aguiar et al., 2013; Dande and Samant, 2018) for predicting smear-negative TB.

Conclusion

Artificial neural networks may be applied as a diagnostic tool for TB prediction and supportive in expanding the role for computer technologies in diagnostics for a rapid management of TB. Therefore, this high correlation (>94% accuracy) with the experimental result of MTB detection may help to choose optimal therapeutic regimens, especially in TB high burden countries. Delays in TB diagnosis and initiation of treatment may allow the emergence of new cases by transmission, and is one of the causes of high drug resistance in TB high burden countries.

The approach developed here may offer and support the rapid diagnosis of MTB with further additions such as drug resistance prediction in near future for better TB management.

Data Availability

The datasets in the present study will be provided upon reasonable request to the corresponding author.

Author Contributions

Manuscript was designed by MK, DW, SM, and LJ. ANN was written and run by AK. Data analysis and manuscript writing were carried out by MK, SA, SM, and AK. Manuscript was revised by DW, LJ, and AK.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The present study was supported by SA and Anwar Sheed Khan, Molecular biologist microbiologist and project director PTRL Peshawar. Deborah L. Devis, University of Adelaide-Shanghai Jiao Tong University Joint Centre for Agriculture and Health, School of Agriculture, Food and Wine, University of Adelaide, Waite Campus, Urrbrae, SA, Australia.

Abbreviations

ANN

artificial neural network

ATH

Ayub Teaching Hospital

ATO

Agency TB officers

CSF

cerebrospinal fluid

DTO

district TB control officers

KPK

Khyber Pakhtunkhwa

MMTH

Mufti Mehmood Teaching Hospital

MTB

Mycobacterium tuberculosis

PMDT

Programmatic Management of Drug Resistant TB

PTRL

Provincial tuberculosis control program

TB

tuberculosis.

Footnotes

Funding. The work was supported by the grants from the Key Research Area grant 2016YFA0501703 of the Ministry of Science and Technology of China, the National Natural Science Foundation of China (Contract Nos. 61832019 and 61503244), the State Key Lab on Microbial Metabolism, and Joint Research Funds for Medical and Engineering and Scientific Research at Shanghai Jiao Tong University (YG2017ZD14). The simulations in this work were supported by the Center for High Performance Computing, Shanghai Jiao Tong University and also Higher Education Commission Islamabad, Pakistan under IRSIP No: 1-8/HEC/HRD/2017/8392.

References

  1. Aguiar F., Pinto J., Torres R., Seixas J., Mello F. (2013). Artificial neural network (ANN) for prediction of pulmonary tuberculosis in hospitalized patients. Eur. Respir. J. 42:4469. [Google Scholar]
  2. Aguiar F. S., Almeida L. L., Ruffino-Netto A., Kritski A. L., Mello F. C., Werneck G. L. (2012). Classification and regression tree (CART) model to predict pulmonary tuberculosis in hospitalized patients. BMC Pulm. Med. 12:40. 10.1186/1471-2466-12-40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arora J., Kumar G., Verma A. K., Bhalla M., Sarin R., Myneedu V. P. (2015). Utility of MPT64 antigen detection for rapid confirmation of mycobacterium tuberculosis complex. J. Glob. Infect. Dis. 7 66–69. 10.4103/0974-777X.154443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Asgharzadeh M., Kafil H. S., Ghorghanlu S., Pourostadi M. (2015). Laboratory cross-contamination of Mycobacterium tuberculosis in Northwest of Iran. Egypt. J. Chest Dis. Tuberc. 64 665–669. 10.1016/j.ejcdt.2015.03.018 [DOI] [Google Scholar]
  5. Attaway S. (2013). Matlab: A Practical Introduction to Programming and Problem Solving. Amsterdam: Elsevier, 10.1016/B978-0-12-405876-7.00014-16 [DOI] [Google Scholar]
  6. CDC Tuberculosis (TB) (2019). Disease: Symptoms and Risk Factors |Features| CDC. Available at: https://www.cdc.gov/features/tbsymptoms/index.html [Accessed September 22, 2018]. [Google Scholar]
  7. Chang J., Arbeláez P., Switz N., Reber C., Tapley A., Davis J. L., et al. (2012). Automated tuberculosis diagnosis using fluorescence images from a mobile microscope. Med. Image Comput. Comput. Assist. Interv. 15 345–352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen Y., Li Y., Narayan R., Subramanian A., Xie X. (2016). Gene expression inference with deep learning. Bioinformatics 32 1832–1839. 10.1093/bioinformatics/btw074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Creswell J., Codlin A. J., Andre E., Micek M. A., Bedru A., Carter E. J., et al. (2014). Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries. BMC Infect. Dis. 14:2. 10.1186/1471-2334-14-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Crowle A. J., Dahl R., Ross E., May M. H. (1991). Evidence that vesicles containing living, virulent Mycobacterium tuberculosis or Mycobacterium avium in cultured human macrophages are not acidic. Infect. Immun. 59 1823–1831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dande P., Samant P. (2018). Acquaintance to artificial neural networks and use of artificial intelligence as a diagnostic tool for tuberculosis: a review. Tuberculosis 108 1–9. 10.1016/j.tube.2017.09.006 [DOI] [PubMed] [Google Scholar]
  12. Dheda K., Gumbo T., Maartens G., Dooley K. E., McNerney R., Murray M., et al. (2017). The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir. Med. 5 291–360. 10.1016/S2213-2600(17)30079-6 [DOI] [PubMed] [Google Scholar]
  13. Dookie N., Rambaran S., Padayatchi N., Mahomed S., Naidoo K. (2018). Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care. J. Antimicrob. Chemother. 73 1138–1151. 10.1093/jac/dkx506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Drew P. J., Monson J. R. T. (2000). Artificial neural networks. Surgery 127 3–11. 10.1067/msy.2000.102173 [DOI] [PubMed] [Google Scholar]
  15. Dunn J. J., Starke J. R., Revell P. A. (2016). Laboratory diagnosis of Mycobacterium tuberculosis infection and disease in children. J. Clin. Microbiol. 54 1434–1441. 10.1128/JCM.03043-3015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ejeta E., Beyene G., Bonsa Z., Abebe G. (2018). Xpert MTB/RIF assay for the diagnosis of Mycobacterium tuberculosis and Rifampicin resistance in high human immunodeficiency virus setting in gambella regional state, southwest ethiopia. J. Clin. Tuberc. Mycobact. Dis. 12 14–20. 10.1016/j.jctube.2018.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Elhassan M. M., Elmekki M. A., Osman A. L., Hamid M. E. (2016). Challenges in diagnosing tuberculosis in children: a comparative study from Sudan. Int. J. Infect. Dis. 43 25–29. 10.1016/j.ijid.2015.12.006 [DOI] [PubMed] [Google Scholar]
  18. Esteva A., Kuprel B., Novoa R. A., Ko J., Swetter S. M., Blau H. M., et al. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature 542 115–118. 10.1038/nature21056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fojnica A., Osmanoviæ A., Badnjeviæ A. (2016). “Dynamical model of tuberculosis-multiple strain prediction based on artificial neural network,” in Proceedings of the 2016 5th Mediterranean Conference on Embedded Computing (MECO), (Piscataway, NJ: IEEE; ), 290–293. 10.1109/MECO.2016.7525763 [DOI] [Google Scholar]
  20. Guillet F., Hamilton H. J. (eds) (2007). Quality Measures in Data Mining. Berlin: Springer-Verlag; 10.1007/978-3-540-44918-8 [DOI] [Google Scholar]
  21. Gulshan V., Peng L., Coram M., Stumpe M. C., Wu D., Narayanaswamy A., et al. (2016). Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 316 2402–2410. 10.1001/jama.2016.17216 [DOI] [PubMed] [Google Scholar]
  22. Hinton G., Deng L., Yu D., Dahl G. E., Mohamed A., Jaitly N., et al. (2012). Deep neural networks for acoustic modeling in speech recognition: the shared views of four research groups. IEEE Signal. Process. Mag. 29 82–97. 10.1109/MSP.2012.2205597 [DOI] [Google Scholar]
  23. Htun Y. M., Khaing T. M. M., Yin Y., Myint Z., Aung S. T., Hlaing T. M., et al. (2018). Delay in diagnosis and treatment among adult multidrug resistant tuberculosis patients in yangon regional tuberculosis center, myanmar: a cross-sectional study. BMC Health Serv. Res. 18:878. 10.1186/s12913-018-3715-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kaushik A. C., Sahi S. (2018). HOGPred: artificial neural network-based model for orphan GPCRs. Neural. Comput. Appl. 29 985–992. 10.1007/s00521-016-2502-2506 [DOI] [Google Scholar]
  25. Kent P. T., Kubica G. P. (1985). Public Health Mycobacteriology: A Guide for the Level III Laboratory. Washington, DC: US Department of Health and Human Services. [Google Scholar]
  26. Khan M. T., Malik S. I., Ali S., Sheed Khan A., Nadeem T., Zeb M. T., et al. (2018). Prevalence of pyrazinamide resistance in khyber pakhtunkhwa, Pakistan. Microb. Drug Resist. 24 1417–1421. 10.1089/mdr.2017.0234 [DOI] [PubMed] [Google Scholar]
  27. Koch A., Cox H., Mizrahi V. (2018). Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment. Curr. Opin. Pharmacol. 42 7–15. 10.1016/j.coph.2018.05.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Krizhevsky A., Sutskever I., Hinton G. E. (2012). “imagenet classification with deep convolutional neural networks,” in Proceedings of the 25th International Conference on Neural Information Processing Systems - Volume 1 NIPS’12, (Red Hook, NY: Curran Associates Inc.), 1097–1105. [Google Scholar]
  29. Kulkarni P., Londhe S., Deo M. (2017). Artificial neural networks for construction management: a review. Soft Comput. Civil Eng. 1 70–88. 10.22115/scce.2017.49580 [DOI] [Google Scholar]
  30. Li X., Ng S.-K., Wang J. T. L. (2013). Biological Data Mining and Its Applications in Healthcare, 1st Edn. New Jersey, NJ: World Scientific Publishing. [Google Scholar]
  31. Lin S.-Y. G., Desmond E. P. (2014). Molecular diagnosis of tuberculosis and drug resistance. Clin. Lab. Med. 34 297–314. 10.1016/j.cll.2014.02.005 [DOI] [PubMed] [Google Scholar]
  32. Melchionda V., Wyatt H., Capocci S., Garcia Medina R., Solamalai A., Katiri S., et al. (2013). Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required? Eur. Respir. J. 42 1148–1150. 10.1183/09031936.00184312 [DOI] [PubMed] [Google Scholar]
  33. Mello F. C. Q., Bastos L. G. V., Soares S. L. M., Rezende V. M., Conde M. B., Chaisson R. E., et al. (2006). Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study. BMC Public Health 6:43. 10.1186/1471-2458-6-43 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Newton S. M., Brent A. J., Anderson S., Whittaker E., Kampmann B. (2008). Paediatric tuberculosis. Lancet Infect. Dis. 8 498–510. 10.1016/S1473-3099(08)70182-70188 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Osman M. K., Mashor M. Y., Jaafar H. (2010). “Detection of mycobacterium tuberculosis in Ziehl-Neelsen stained tissue images using Zernike moments and hybrid multilayered perceptron network,” in Proceedings of the 2010 IEEE International Conference on Systems, Man and Cybernetics, (Piscataway, NY: IEEE; ), 4049–4055. 10.1109/ICSMC.2010.5642191 [DOI] [Google Scholar]
  36. Pandey S., Congdon J., McInnes B., Pop A., Coulter C. (2017). Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience. Pathology 49 70–74. 10.1016/j.pathol.2016.10.004 [DOI] [PubMed] [Google Scholar]
  37. Parsons L. M., Somoskövi Á, Gutierrez C., Lee E., Paramasivan C. N., Abimiku A., et al. (2011). Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin. Microbiol. Rev. 24 314–350. 10.1128/CMR.00059-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Putin E., Mamoshina P., Aliper A., Korzinkin M., Moskalev A., Kolosov A., et al. (2016). Deep biomarkers of human aging: application of deep neural networks to biomarker development. Aging 8 1021–1033. 10.18632/aging.100968 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Schaberg T., Rebhan K., Lode H. (1996). Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis. Eur. Respir. J. 9 2026–2030. 10.1183/09031936.96.09102026 [DOI] [PubMed] [Google Scholar]
  40. Sebban M., Mokrousov I., Rastogi N., Sola C. (2002). A data-mining approach to spacer oligonucleotide typing of Mycobacterium tuberculosis. Bioinformatics 18 235–243. 10.1093/bioinformatics/18.2.235 [DOI] [PubMed] [Google Scholar]
  41. Seggern D. H. (2016). CRC Standard Curves and Surfaces with Mathematica. Boca Raton, FL: CRC, 10.1201/b16001 [DOI] [Google Scholar]
  42. Seung K. J., Keshavjee S., Rich M. L. (2015). Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring Harb. Perspect. Med. 5:a017863. 10.1101/cshperspect.a017863 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Socher R., Lin C. C. Y., Ng A. Y., Manning C. D. (2011). “Parsing natural scenes and natural language with recursive neural networks,” in Proceedings of the 28th International Conference on International Conference on Machine Learning ICML’11, (Washington, DC: Omni press; ), 129–136. [Google Scholar]
  44. Solari A., Laurà M., Salsano E., Radice D., Pareyson D., CMT-Triaal Study Group (2008). Reliability of clinical outcome measures in charcot-marie-tooth disease. Neuromuscul. Disord. 18 19–26. 10.1016/j.nmd.2007.09.006 [DOI] [PubMed] [Google Scholar]
  45. Sollich P., Krogh A. (1996). “Learning with ensembles: how over-fitting can be useful,” in Advances in Neural Information Processing Systems, eds Touretzky D. S., Mozer M. C., Hasselmo M. E. (Cambridge, MA: MIT Press; ), 190–196. [Google Scholar]
  46. Tadesse M., Abebe G., Bekele A., Bezabih M., Yilma D., Apers L., et al. (2018). Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study. Clin. Microbiol. Infect. 10.1016/j.cmi.2018.12.018 [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  47. WHO (2017). WHO | Global Tuberculosis Report 2017. Available at: http://www.who.int/tb/publications/global_report/en/ [Accessed November 12, 2017]. [Google Scholar]
  48. Wisnivesky J. P., Bonomi M., Henschke C., Iannuzzi M., McGinn T. (2005). Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 128 1461–1467. 10.1378/chest.128.3.1461 [DOI] [PubMed] [Google Scholar]
  49. World Health Organization [WHO] (2018). Global Tuberculosis Report 2018. Geneva: World Health Organization. [Google Scholar]
  50. World Health Organization [WHO] (2011). Standards and operational guidance for ethics review of health-related research with human participants. Geneva: : World Health Organization; Available at: http://www.who.int/iris/handle/10665/44783 [PubMed] [Google Scholar]
  51. Yagui M., Perales M. T., Asencios L., Vergara L., Suarez C., Yale G., et al. (2006). Timely diagnosis of MDR-TB under program conditions: is rapid drug susceptibility testing sufficient? Int. J. Tuberc. Lung Dis. 10838–843. [PMC free article] [PubMed] [Google Scholar]
  52. Zhang S., Zhou J., Hu H., Gong H., Chen L., Cheng C., et al. (2016). A deep learning framework for modeling structural features of RNA-binding protein targets. Nucleic Acids Res. 44 e32. 10.1093/nar/gkv1025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zhang X., Pan F., Wang W. (2010). “Finding high-order correlations in high-dimensional biological data,” in Link Mining: Models, Algorithms, and Applications, eds Yu P. S., Han J., Faloutsos C. (New York, NY: Springer; ), 505–534. 10.1007/978-1-4419-6515-8_19 [DOI] [Google Scholar]
  54. Zheng H., Chruszcz M., Lasota P., Lebioda L., Minor W. (2008). Data mining of metal ion environments present in protein structures. J. Inorg. Biochem. 102 1765–1776. 10.1016/j.jinorgbio.2008.05.006 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets in the present study will be provided upon reasonable request to the corresponding author.


Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES